Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)

Recent success of novel therapies has improved treatment of chronic lymphocytic leukemia (CLL) patients, but most of them still require several treatment regimes. To improve treatment choice, prognostic markers suitable for prediction of disease outcome are required. Several molecular/genetic marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaban, Kübra, Greiner, Sarah M., Holzmayer, Samuel, Tandler, Claudia, Meyer, Sophie, Hinterleitner, Clemens, Salih, Helmut R., Märklin, Melanie, Heitmann, Jonas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622208/
https://www.ncbi.nlm.nih.gov/pubmed/34829391
http://dx.doi.org/10.3390/diagnostics11112041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622208/
https://www.ncbi.nlm.nih.gov/pubmed/34829391
http://dx.doi.org/10.3390/diagnostics11112041

Ejemplares similares